Breakthrough Therapeutic Antibodies
Scott discusses the development of therapeutic antibodies effective against various viruses, including SARS CoV two. He highlights the challenges in scaling up manufacturing capacity and the potential for pill-based drugs like atamiflu for COVID. James questions why these drugs weren't developed sooner, reflecting on the impact of lacking such treatments during his illness.In this clip
From this podcast
The James Altucher Show
760 - Dr. Scott Gottlieb (Part 2): Uncontrolled Spread: How We Can Defeat the Next Pandemic
Related Questions